MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from private
placement
$3,305,303
Proceeds from exercise of
warrants
$991,366
Proceeds from
convertible notes payable ...
$499,010
Proceeds from
convertible notes payable ...
$390,000
Net cash provided by
financing activities
$4,637,995
Effect of exchange rate
changes on cash and cash...
$20,264
Canceled cashflow
$547,684
Net increase in cash
and cash...
$463,170
Canceled cashflow
$4,195,089
Repayment of convertible
notes payable third...
$277,284
Repayment of convertible
notes payable related...
$150,000
Repayment of short-term
bank loans
$120,400
Stock-based compensation
$4,142,816
Loss on impairment of
equity investment
-$803,008
Amortization of right-of-use
asset
$479,504
Other non-cash
expenses, net
$351,085
Loss on investment in
equity securities
-$192,759
Accrued expenses and
other current...
$152,207
Depreciation
$25,330
Taxes payables
$11,964
Inventory write-down
$11,460
Repayment from related
parties
$203,026
Net cash used in
operating activities
-$2,986,299
Net cash used in
investing activities
-$1,208,790
Canceled cashflow
$6,170,133
Canceled cashflow
$203,026
Net loss
-$8,376,959
Loan to related
parties
$1,406,022
Operating lease
liabilities
-$474,479
Due from related
parties
$136,501
Prepaid expenses and
other current assets
$71,653
Contract liabilities
-$68,515
Tenant security
deposit
-$16,865
Inventory
$11,460
Transaction costs for
acquiring land
$5,794
Back
Back
Cash Flow
source: myfinsight.com
ABVC BIOPHARMA, INC. (ABVC)
ABVC BIOPHARMA, INC. (ABVC)